Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals

The drugmaker is demanding claims data, alleging some hospitals are double-dipping on federal discounts.
Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
An Eli Lilly office in San Diego on Sept. 17, 2020. Mike Blake/Reuters
Lawrence Wilson
Lawrence Wilson
Senior Reporter
|Updated:

INDIANAPOLIS—The nation’s largest pharmaceutical company and biggest hospitals are headed for a showdown over federally mandated drug discounts on June 8.

That’s the deadline set by Eli Lilly for the hospitals to provide claims data, not including personal information, to demonstrate that they are not double-dipping on federal discounts and rebates. Lilly will end the discounts for hospitals that do not comply by the deadline.